CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Craig Morgan

OPENALEX: A5045508438↗ORCID: 0000-0002-1386-2369↗

Affiliations

Organizations

Cambridgeshire and Peterborough NHS Foundation Trustauthorship · GB Central Institute of Mental Healthauthorship · DE Heidelberg Universityauthorship · DE King's College Londonauthorship · GB Kings Health Partnersauthorship · GB Maastricht Universityauthorship · NL Maastricht University Medical Centreauthorship · NL National Health Serviceauthorship · GB National Institute for Health and Care Researchauthorship · GB Neurosciences Instituteauthorship · US Public Health Dayton & Montgomery Countyauthorship · US South London and Maudsley NHS Foundation Trustauthorship · GB University Hospital Heidelbergauthorship · DE University of Cambridgeauthorship · GB University of the West Indiesauthorship · TT

Public evidence

21 connected articles

Improving our understanding of the social determinants of mental health: A data linkage study of mental health records and the 2011 UK census.2023 · medRxiv Clusters of social and substance use-related risks are associated with the duration of untreated psychosis.2026 · Europe PMC Methylomic signature of current cannabis use in two first-episode psychosis cohorts.2025 · Europe PMC The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies.2024 · Europe PMC Cannabis use and cognitive biases in people with first-episode psychosis and their siblings.2024 · Europe PMC Neighbourhoods & recovery from psychosis in Trinidad: A qualitative study.2024 · Europe PMC The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study.2024 · Europe PMC Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study.2023 · Europe PMC Development and Validation of Predictive Model for a Diagnosis of First Episode Psychosis Using the Multinational EU-GEI Case-control Study and Modern Statistical Learning Methods.2023 · Europe PMC First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data2023 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 09/09/2026.

The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study.2023 · Europe PMC

Cannabis use and psychotic disorders in diverse settings in the Global South: findings from INTREPID II.2023 · Europe PMC

Need for care, adversity exposure and perceived stress in clinical and healthy voice-hearers.2021 · PubMed Central Open Access

Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.2021 · PubMed Central Open Access

The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.2021 · PubMed Central Open Access

The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study.2021 · PubMed Central Open Access

Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: results from the EU-GEI case-control study.2021 · PubMed Central Open Access

The Maudsley environmental risk score for psychosis.2020 · PubMed Central Open Access

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.2019 · PubMed Central Open Access

Role of Environmental Confounding in the Association between FKBP5 and First-Episode Psychosis2014 · PubMed Central Open Access

Importance of Thinking Locally for Mental Health: Data from Cross-Sectional Surveys Representing South East London and England2012 · PubMed Central Open Access

Craig Morgan - Medical Cannabis Research Engine